Gliomedin drives gastric cancer cell proliferation and migration, correlating with a poor prognosis

Gastric cancer (GC) is a prevalent global malignancy, often diagnosed at advanced stage due to a lack of early symptoms and reliable markers. Previous research has identified gliomedin (GLDN) as a potential predictive marker for poor prognosis in cancer patients. However, the specific relationship b...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Xue You, Minghe Wang, Xuejing Wang, Xiaotong Wang, Yuting Cheng, Chuan Zhang, Qingrun Miao, Ying Feng
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2024-09-01
סדרה:Heliyon
נושאים:
Gliomedin
Gastric cancer
Viability
Proliferation and migration
RNA-Sequencing
Poor prognosis
גישה מקוונת:http://www.sciencedirect.com/science/article/pii/S2405844024141849
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים